01941nam 2200565 a 450 991082426030332120240410171208.01-61668-478-X(CKB)2560000000068770(EBL)3019875(SSID)ssj0000415799(PQKBManifestationID)12173982(PQKBTitleCode)TC0000415799(PQKBWorkID)10416286(PQKB)11606005(MiAaPQ)EBC3019875(Au-PeEL)EBL3019875(CaPaEBR)ebr10674883(OCoLC)923662021(EXLCZ)99256000000006877020100122d2010 uy 0engur|n|---|||||txtccrDevelopment of new MDR-tuberculosis drugs[electronic resource] /Jarmila Vinšová and Martin Krátký1st ed.New York Nova Science Publishers/Nova Biomedicalc20101 online resource (112 p.)Pharmacology-research, safety testing and regulationDescription based upon print version of record.1-61668-233-7 Includes bibliographical references and index.Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.Pharmacology-research, safety testing, and regulation series.Antitubercular agentsMultidrug-resistant tuberculosisChemotherapyAntitubercular agents.Multidrug-resistant tuberculosisChemotherapy.615.5/8Vinšová Jarmila1711024Krátký Martin1960-1711025MiAaPQMiAaPQMiAaPQBOOK9910824260303321Development of new MDR-tuberculosis drugs4102055UNINA